Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) today announced that positive top-line results from the lead-in portion of its IGNITE 2 clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE